Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RITUXIMAB vs RIZATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RITUXIMAB vs RIZATRIPTAN: Safety Overview

Metric RITUXIMAB RIZATRIPTAN
Total FAERS Reports 178,614 2,896
Deaths Reported 28,910 68
Death Rate 16.2% 2.3%
Hospitalizations 54,631 479
Average Patient Age 54.6 yrs 44.6 yrs
% Female Patients 64.3% 77.2%
FDA Approval Date N/A Apr 14, 2023
Manufacturer Genentech, Inc. Panacea Biotec Limited
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued